Cargando…
Treatment of Multiorgan Sarcoidosis With Tofacitinib
OBJECTIVE: Sarcoidosis is an idiopathic inflammatory disorder that is difficult to treat. There is accumulating evidence that constitutive activation of Janus kinase–signal transducer and activator of transcription (JAK‐STAT) signaling occurs in sarcoidosis and represents a target for treatment. Her...
Autores principales: | Damsky, William, Young, Bryan D., Sloan, Brett, Miller, Edward J., Obando, J. Antonio, King, Brett |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011417/ https://www.ncbi.nlm.nih.gov/pubmed/31916703 http://dx.doi.org/10.1002/acr2.11112 |
Ejemplares similares
-
Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
por: Talty, Ronan, et al.
Publicado: (2021) -
Treatment of granuloma annulare with tofacitinib 2% ointment
por: Damsky, William, et al.
Publicado: (2019) -
Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy
por: Singh, Katelyn, et al.
Publicado: (2020) -
Sisaipho alopecia areata treated with tofacitinib and oral minoxidil
por: Talty, Ronan, et al.
Publicado: (2022) -
Idiopathic erythema multiforme: Evidence of underlying Janus kinase–signal transducer and activator of transcription activation and successful treatment with tofacitinib
por: Damsky, William, et al.
Publicado: (2016)